IceCure Medical Ltd. - נכסים נקיים למניה בודדת ICCM

IceCure Medical Ltd (ICCM) is implementing eco-friendly cancer treatment methods, reducing the volume of medical waste. An analysis of the book value per share allows for tracking the dynamics of net assets, where the value 3.49 represents the latest figure. The company's prospects rely on AI-driven cryofreezing systems, while current growth is driven by active sales of ProSense devices with potential for expansion in the US market.
IceCure Medical Ltd. - פילוחים אנליטיים ומדדי מפתח (ICCM)

Book value per share determines the intrinsic value of a business by dividing the total net assets by the number of outstanding shares to identify the actual capital net of liabilities. In the case of IceCure Medical Ltd (ICCM), the BVPS trend reflects how effectively unique cryoablation technologies and stable gas sales revenue are converted into the resilience of the company's equity.